DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the APOLLO HOSPITALS ENTER. L (APOLLOHOSP) share price today?

APOLLO HOSPITALS ENTER. L (APOLLOHOSP) is trading at ₹8,826 on the NSE, down 0.70% on the day. Source: DocStoX.

What is the PE ratio of APOLLO HOSPITALS ENTER. L?

APOLLO HOSPITALS ENTER. L has a price-to-earnings (PE) ratio of 65.4 in the Healthcare sector.

What is the market capitalisation of APOLLO HOSPITALS ENTER. L?

APOLLO HOSPITALS ENTER. L has a market capitalisation of approximately ₹1,26,936 crore.

APOLLO HOSPITALS ENTER. L

F&O

APOLLOHOSP·NSE·Healthcare

₹8,826.00▼ -62.00 (-0.70%)

Healthcare · Hospital

High-quality returns — 22% on equity

NIFTY 50NIFTY 100NIFTY 200

Day₹8782.00

₹8892.00

52W₹6697

₹900992%

Open

₹8875.00

High

₹8892.00

Low

₹8782.00

Prev Close

₹8888.00

Volume

1.45L

VWAP

₹8828.83

Snapshot

Key fundamentals

Market Cap

₹1.27L Cr

P/E Ratio

65.36Expensive

P/B Ratio

13.42

EPS

₹135.04

Book Value

₹659.00

ROE

22.10%Strong

ROCE

18.00%Decent

Dividend Yield

0.11%

Debt / Equity

0.90Moderate

Face Value

₹5.00

52W High

₹9009.00

52W Low

₹6696.50

Sector

Healthcare

Industry

Hospital

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹1,080

▼ 87.8%downside

Trading at ₹8,826 — 88% above our estimate

BearFair valueBull

₹918₹1,080₹1,415

/100

Business quality — Solid

Growth 80Profitability 59Efficiency 25Valuation 28

Plain English

Our view

High-quality returns — 22% on equity
Strong returns on equity (22%)
Expensive — trades at 65× earnings

Strengths

Strong returns on equity (22%)
Profit growing 33% a year

Risks

Expensive — trades at 65× earnings
Fundamental red flags (Piotroski 2/9)

How we got there

Fair value methods

Residual income

22% ROE fading to 13% over ~10 yrs, on ₹659 book

₹987

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹1,415

Analyst target

No analyst coverage

—

Blended fair value₹1,080

What the numbers say

Investment thesis

Bull case

Strong returns on equity (22%)
Profit growing 33% a year

Bear case

Expensive — trades at 65× earnings
Fundamental red flags (Piotroski 2/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

65.4Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

22.1%Strong

Above 15% is considered healthy for Indian equities

ROCE

18.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.90Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1.27L Cr

P/B

13.42

EPS

₹135.04

Div Yield

0.11%

What changed

Recent changes

Foreign investors-1.1% stake last quarter
Domestic institutions+1.0% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 65.4×

Growth

Steady

+15% rev CAGR

Profitability

Excellent

22.1% ROE

Financial health

Comfortable

D/E 0.90

Momentum

N/A

No technicals

Today

Trading activity

Delivery %49.9%

Turnover₹12763.22L Cr

Trades28,000

VWAP₹8828.83

Face value₹5.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+14.9%

+19.0%

10Y

+15.2%

Profit

+33.4%

+71.0%

10Y

+23.9%

EPS

+33.3%

+66.8%

10Y

+23.0%

Profile

Pros

Company has delivered good profit growth of 77.8% CAGR over last 5 years
Company has been maintaining a healthy dividend payout of 17.7%

Watch-outs

Cons

Stock is trading at 13.4 times its book value
Company might be capitalizing the interest cost

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Foreign investors sold 1.13 pts; domestic institutions added 0.96 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

28%

Promoter

Promoters

28.0%0.00

Public

6.5%+0.14

FII / FPI

41.5%-1.13

DII

23.7%+0.96

Total shareholders

1,74,281-329 QoQ

Quarterly trend

Ownership over time

Q1 FY27

Promoter28.02%

FII41.49%

DII23.72%

Government0.23%

Public6.53%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

F&O